Sandra Milligan is Head of Research & Development at Organon & Co. (OGN). They have made 2 open-market trades across 1 company since 2023, most recently 2025-08-19.
CIK 0001859810
2 open-market purchases totalling $75K since 2023, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.